Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
36
IMYSY Quote, Financials, Valuation and Earnings
Last price:
$5.72
Seasonality move
:
0%
Day range:
$5.72 - $5.72
52-week range:
$4.80 - $6.43
Dividend yield:
5.67%
P/E ratio:
122.42x
P/S ratio:
0.65x
P/B ratio:
1.09x
Volume:
152
Avg. volume:
400
1-year change:
-9.49%
Market cap:
$2.4B
Revenue:
$3.9B
EPS (TTM):
-$0.42
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Imerys SA has -- downside to fair value with a price target of -- per share.
IMYSY vs. S&P 500
-
Over the past 5 trading days, Imerys SA has underperformed the S&P 500 by -1.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Imerys SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Imerys SA revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Imerys SA reported revenues of $886.8M.
Earnings Growth
-
Imerys SA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Imerys SA reported earnings per share of $0.12.
Enterprise value:
3.7B
EV / Invested capital:
--
Price / LTM sales:
0.65x
EV / EBIT:
14.44x
EV / Revenue:
0.99x
PEG ratio (5yr expected):
--
EV / Free cash flow:
69.99x
Price / Operating cash flow:
46.03x
Enterprise value / EBITDA:
6.36x
Gross Profit (TTM):
$1.1B
Return On Assets:
-1.45%
Net Income Margin (TTM):
-4.76%
Return On Equity:
-3.1%
Return On Invested Capital:
-1.92%
Operating Margin:
9.01%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4.1B | $4.1B | $3.9B | $963.2M | $886.8M | |
| Gross Profit | $1.3B | $1B | $1.1B | -- | -- | |
| Operating Income | $359.6M | $298.1M | $296.8M | -- | -- | |
| EBITDA | $672.7M | $626M | $614.5M | -- | -- | |
| Diluted EPS | $0.59 | $0.13 | -$0.25 | -$0.34 | $0.12 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $3B | $2.8B | $2.9B | -- | |
| Total Assets | $8.6B | $8.4B | $7.5B | $7.7B | -- | |
| Current Liabilities | $1.7B | $1.9B | $1.3B | $1.7B | -- | |
| Total Liabilities | $4.9B | $4.8B | $4B | $4.2B | -- | |
| Total Equity | $3.7B | $3.6B | $3.6B | $3.5B | -- | |
| Total Debt | $2.4B | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $600.5M | $551M | $609.1M | $311.6M | $249.9M | |
| Cash From Investing | -$338M | $204.7M | -$415.4M | $420.1M | -$134.7M | |
| Cash From Financing | -$267M | -$719.8M | -$279.1M | -$795.4M | -$69.1M | |
| Free Cash Flow | $155M | $145M | $184.3M | $117.3M | $65.7M | |
IMYSY
Sector
Market Cap
$2.4B
--
Price % of 52-Week High
88.96%
--
Dividend Yield
5.67%
--
Shareholder Yield
5.92%
--
1-Year Price Total Return
-9.49%
--
Beta (5-Year)
--
--
Dividend yield:
5.67%
Annualized payout:
$0.29
Payout ratio:
74.48%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.72
200-day SMA
Buy
Level
$5.61
Bollinger Bands (100)
Buy
Level
5.24 - 5.74
Chaikin Money Flow
Sell
Level
-4.6K
20-day SMA
Sell
Level
$5.72
Relative Strength Index (RSI14)
Buy
Level
51.76
ADX Line
Buy
Level
14.99
Williams %R
Neutral
Level
-68.5714
50-day SMA
Buy
Level
$5.52
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
1.7K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3381)
Buy
CA Score
(Annual)
Level (-0.2497)
Buy
Beneish M-Score
(Annual)
Level (-2.9076)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.8821)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Imerys SA engages in the exploration, mining and processing of minerals. It operates through the Refractory, Abrasives and Construction, and Performance Minerals segments. The Refractory, Abrasives and Construction segment focuses on serving the market on a global use. The Performance Minerals segment involves the offering of plastics, paints and coatings, filtration, ceramics, renewable energy, paper and board markets. The company was founded on April 22, 1880 and is headquartered in Paris, France.
Stock Forecast FAQ
In the current month, IMYSY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IMYSY average analyst price target in the past 3 months is --.
-
Where Will Imerys SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Imerys SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Imerys SA?
Analysts are divided on their view about Imerys SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Imerys SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Imerys SA's Price Target?
The price target for Imerys SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IMYSY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Imerys SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IMYSY?
You can purchase shares of Imerys SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Imerys SA shares.
-
What Is The Imerys SA Share Price Today?
Imerys SA was last trading at $5.72 per share. This represents the most recent stock quote for Imerys SA. Yesterday, Imerys SA closed at $5.72 per share.
-
How To Buy Imerys SA Stock Online?
In order to purchase Imerys SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get IMYSY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IMYSY
Sector
P/E ratio
122.42x
--
PEG ratio
--
--
P/B ratio
1.09x
--
Price / LTM sales
0.65x
--
Growth Metrics
IMYSY
Sector
Revenue growth
-7.93%
--
Earnings growth
61.76%
--
Revenue (5-year growth)
-4.36%
--
Earnings forecast
--
--
Profitability
IMYSY
Sector
Profitability FY 2024
$1.1B
--
Return on invested capital
-1.92%
--
Return on assets
-1.45%
--
Return on equity
-3.1%
--
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Jan
29
Balance Sheet
IMYSY
Sector
Total cash
$666.4M
--
Short term investments
$5.6M
--
Total assets
$6.9B
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
Sell
32
SMX alert for Dec 24
SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
